Correction to: British Journal of Pharmacology (2006) 148, 102–113. doi:10.1038/sj.bjp.0706699
The authors have recently notified us of an error in the above paper. It has come to their attention that Figure 5 was published incorrectly.
Figure 5.
OL135 reverses mechanical allodynia in two rat models of pain. (a) Rats were subjected to a mild thermal injury as described, and allodynia was measured using von Frey hairs. OL135 treatment (20 mg kg−1 i.p.) resulted in a reduction of the allodynia that is comparable to 1 mg kg−1 morphine which was maximal at 30 min post treatment and still significant at 60 min post treatment compared with the vehicle (two-way ANOVA with Bonferroni's post-tests, ***P<0.001, df=2, F=30.97). (b) Rats with a fully developed SNL neuropathic lesion were dosed with either morphine (3 mg kg−1 i.p.) or OL135 (20 mg kg−1 i.p.). OL135 reversed the mechanical allodynia with an efficacy similar to that of morphine, and maximal effect at 30 min, which was still significant at 60 min compared to vehicle (two-way ANOVA with Bonferroni's post-tests, *** P<0.001, df=2, F=31.04).
The correct figure is shown below:
The authors apologise for this mistake.